Lv1
10 积分 2025-07-10 加入
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer
1年前
已完结
The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta-analysis
1年前
已完结
Efficacy and safety of olaparib in advanced ovarian cancer: a meta-analysis
1年前
已完结